Biological Industries USA Announces Mesenchymal Stromal and Stem Cell Research Award, Including Conference Travel, Laboratory Reagents, and Potential Publicity for Researchers

CROMWELL, Conn. & BOSTON--()--Biological Industries USA (BI-USA), the North American commercial division of Biological Industries, one of the world’s leading suppliers to the life sciences industry, is proud to announce the BI-USA Mesenchymal Stem/Stromal Cell (MSC) Research Award, designed to encourage cutting-edge scientific research utilizing MSCs. Awards for MSC researchers include BI-USA’s cell culture reagents and services valued up to $25,000, a travel grant for attendance and presentation opportunities at a scientific conference, as well as scientific consultation and support for up to six months of the project duration. Additionally, the winning researcher’s project may be featured in promotional materials from BI-USA.

“Our MSC Research Award is intended to enable more scientists in the field of regenerative medicine to achieve their MSC research objectives”

“Our MSC Research Award is intended to enable more scientists in the field of regenerative medicine to achieve their MSC research objectives,” commented Tanya Potcova, CEO of BI-USA. “MSCs hold extraordinary potential for therapeutic applications through their wide accessibility from a variety of tissue sources, ready expansion in culture, and capacity to differentiate into multiple lineages. MSCs are a vital tool for many regenerative medicine applications, including tissue regeneration, drug screening and discovery, and treatment of a wide range of immune-related diseases. At BI-USA we want to encourage this promising research, and sponsoring this award is just one of a variety ways we are doing so.”

BI-USA made the announcement today at the 2018 Cell & Gene Therapy World Conference, being held January 22-25 at the Hyatt Regency, Miami. Questions about the MSC Research Award can be answered by the BI-USA team at Booth 107 throughout the conference.

To apply, researchers must provide basic information about their study design, specific aims of their proposed MSC research study, as well as significance of the findings in downstream pre-clinical or therapeutic applications.

More information about the BI-USA’s MSC Research Award is available at All entries must be received before the stated deadline of March 1, 2018 in order to be considered. Proposals may be submitted via the online form or e-mail. Please review all Terms and Conditions before applying.

About Biological Industries (BI)

Biological Industries ( is one of the world’s leading and trusted suppliers to the life sciences industry, with over 35 years’ experience in cell culture media development and GMP manufacturing. BI’s products range from classical cell culture media to supplements and reagents for stem cell research and potential cell therapy applications, to serum-free media and many other products for animal cell culture and molecular biology. BI is committed to a Culture of Excellence through advanced manufacturing and quality-control systems, regulatory expertise, in-depth market knowledge, and extensive technical customer-support, training, and R&D capabilities.

Biological Industries USA (BI-USA) is the US commercialization arm of BI, with facilities in Cromwell, Connecticut. Members of the BI-USA team share a history and expertise of innovation and success in the development of leading-edge technologies in stem cell research, cellular reprogramming, and regenerative medicine.

To receive ongoing BI communications, please join our email list or connect with the company on LinkedInTwitter, and Facebook.


Biological Industries USA
Tanya Potcova, 617-359-2424
Gotham Communications, LLC
Bill Douglass, 646-504-0890

Recent Stories

RSS feed for Biological Industries USA

Release Summary

BI-USA announces MSC Research Award for stem cell researchers, including Conference Travel, Lab Reagents & Potential Publicity for Researchers.

Biological Industries USA